Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Moffett's solution is a compounded topical pharmaceutical preparation used in otorhinolaryngological (ENT) procedures, particularly sinonasal surgeries. It is a mixture consisting of cocaine hydrochloride (a local anesthetic), adrenaline (epinephrine, a vasoconstrictor), sodium bicarbonate (a buffering agent), and 0.9% sodium chloride (a diluent). First described by Major A.J. Moffett of the Royal Army Medical Corps in 1941, the solution is applied topically to the nasal mucosa to produce profound vasoconstriction and local anesthesia. This combination is used to reduce intraoperative blood loss and improve surgical visualization during procedures for conditions such as chronic rhinosinusitis and nasal obstruction. Clinical studies have compared its efficacy and side effect profile, such as postoperative throat pain, to other topical agents like Co-phenylcaine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Moffett's solution.